217 related articles for article (PubMed ID: 1640484)
41. Molecular genetics of the retinoblastoma suppressor gene.
Bookstein R; Lee WH
Crit Rev Oncog; 1991; 2(3):211-27. PubMed ID: 1888791
[TBL] [Abstract][Full Text] [Related]
42. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
43. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
[TBL] [Abstract][Full Text] [Related]
44. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
45. p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy.
Jahnson S; Risberg B; Karlsson MG; Westman G; Bergström R; Pedersen J
Eur Urol; 1995; 28(2):135-42. PubMed ID: 8529739
[TBL] [Abstract][Full Text] [Related]
46. RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines.
Ali AA; Marcus JN; Harvey JP; Roll R; Hodgson CP; Wildrick DM; Chakraborty A; Boman BM
FASEB J; 1993 Jul; 7(10):931-7. PubMed ID: 8344490
[TBL] [Abstract][Full Text] [Related]
47. [Prognostic value of P53, Ki67, and Rb protein in infiltrating bladder tumors].
Sánchez Zalabardo D; Rosell Costa D; Fernández Montero JM; López Ferrandis J; Arocena García-Tapia J; Jiménez Garín S; de Alava Casado E; Robles García JE; Zudaire Bergera JJ; Berián Polo JM
Actas Urol Esp; 2002 Feb; 26(2):98-103. PubMed ID: 11989434
[TBL] [Abstract][Full Text] [Related]
48. The loss of retinoblastoma gene in association with c-myc and transforming growth factor-beta 1 gene expression in human bladder cancer.
Kubota Y; Miyamoto H; Noguchi S; Shuin T; Kitamura H; Xu HJ; Hu SX; Benedict WF
J Urol; 1995 Aug; 154(2 Pt 1):371-4. PubMed ID: 7609100
[TBL] [Abstract][Full Text] [Related]
49. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
[TBL] [Abstract][Full Text] [Related]
50. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
51. Rb deficiency accelerates progression of carcinoma of the urinary bladder in vivo and in vitro through inhibiting autophagy and apoptosis.
Wang CY; Xu ZB; Wang JP; Jiao Y; Zhang B
Int J Oncol; 2017 Apr; 50(4):1221-1232. PubMed ID: 28259945
[TBL] [Abstract][Full Text] [Related]
52. Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker.
Pignot G; Bieche I; Vacher S; Güet C; Vieillefond A; Debré B; Lidereau R; Amsellem-Ouazana D
Eur Urol; 2009 Oct; 56(4):678-88. PubMed ID: 18513850
[TBL] [Abstract][Full Text] [Related]
53. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
[TBL] [Abstract][Full Text] [Related]
54. Altered expression of the human retinoblastoma gene in monocytic leukaemias.
Weide R; Parviz B; Pflüger KH; Havemann K
Br J Haematol; 1993 Mar; 83(3):428-32. PubMed ID: 8485048
[TBL] [Abstract][Full Text] [Related]
55. Mutation of cell cycle regulators and their impact on superficial bladder cancer.
Rabbani F; Cordon-Cardo C
Urol Clin North Am; 2000 Feb; 27(1):83-102, ix. PubMed ID: 10696248
[TBL] [Abstract][Full Text] [Related]
56. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Jiang W; Zhang YJ; Kahn SM; Hollstein MC; Santella RM; Lu SH; Harris CC; Montesano R; Weinstein IB
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9026-30. PubMed ID: 8415648
[TBL] [Abstract][Full Text] [Related]
57. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
58. Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer.
Romkes M; Chern HD; Lesnick TG; Becich MJ; Persad R; Smith P; Branch RA
Carcinogenesis; 1996 May; 17(5):1057-62. PubMed ID: 8640913
[TBL] [Abstract][Full Text] [Related]
59. Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation.
Trudel M; Mulligan L; Cavenee W; Margolese R; Côté J; Gariépy G
Hum Pathol; 1992 Dec; 23(12):1388-94. PubMed ID: 1468776
[TBL] [Abstract][Full Text] [Related]
60. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
